Hye Jin Kang
Overview
Explore the profile of Hye Jin Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
2020
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cho Y, Kim S, Kim P, Jo M, Park S, Choi Y, et al.
Biomolecules
. 2025 Feb;
15(2).
PMID: 40001594
G-protein coupled receptors (GPCRs), the largest family of integral membrane proteins, enable cells to sense and appropriately respond to the environment through mediating extracellular signaling to intercellular messenger molecules. GPCRs'...
2.
Jang Y, Kim H, Ryu S, Kim M, Kim B, Jung H, et al.
Transl Cancer Res
. 2024 Dec;
13(11):6018-6027.
PMID: 39697762
Background: Prior prospective studies have demonstrated the efficacy of poly(adenosine diphosphate-ribose) polymerase inhibitors (PARPis) in various cancers with mutations in the breast cancer gene (), such as ovarian and breast...
3.
Kang H, Krumm B, Tassou A, Geron M, DiBerto J, Kapolka N, et al.
Cell
. 2024 Dec;
187(26):7433-7449.e20.
PMID: 39631393
Designer receptors exclusively activated by designer drugs (DREADDs) are chemogenetic tools for remotely controlling cellular signaling, neural activity, behavior, and physiology. Using a structure-guided approach, we provide a peripherally restricted...
4.
Jung J, Jung S, Lee J, Do Y, Kang K, Lee J, et al.
Sci Rep
. 2024 Oct;
14(1):24325.
PMID: 39414879
Tandem autologous stem cell transplantation can improve the prognosis of patients with multiple myeloma. However, the precise role of tandem transplantation remains debatable. We evaluated the clinical benefits of tandem...
5.
Park S, Lee J, Kang H, Hong Y, Oh A, Kim H
Clin Lab
. 2024 Sep;
70(9).
PMID: 39257124
Background: Chronic myeloid leukemia (CML), a myeloproliferative neoplasm defined by the BCR::ABL1 fusion gene arising from the Philadelphia chromosome (Ph) translocation t(9:22)(q34;q11), exhibits diverse clinical courses often influenced by additional...
6.
Lee S, Kim M, Kwak Y, Kang H
Medicina (Kaunas)
. 2024 Aug;
60(8).
PMID: 39202645
: This study aimed to investigate the clinical course and characteristics of late toxicity over time following the completion of definitive radiotherapy (RT) in patients with cervical cancer. : We...
7.
Lee I, Byun B, Kim B, Choi C, Kang H, Kang C, et al.
Nucl Med Commun
. 2024 Aug;
45(10):865-873.
PMID: 39155810
Background: This study aimed to evaluate the biodistribution of 64 Cu-DOTA-rituximab and its diagnostic feasibility for lymphoma using CD20-targeted 64 Cu-DOTA-rituximab PET/computed tomography (PET/CT). Methods: A prospective study involving six...
8.
Kang H, Kim M, Kwak Y, Lee S
Medicina (Kaunas)
. 2024 Jul;
60(7).
PMID: 39064478
: Despite rapid advances in targeted therapies for renal cell carcinoma (RCC), bone metastases remain a major problem that significantly increases morbidity and reduces patients' quality of life. Conventional fractionated...
9.
Kwon J, Kim H, Lee J, Hong Y, Kang H, Jang Y
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001408
Rising cancer survival rates have led to an increased risk of multiple primary cancers (MPCs). Data on MPCs in South Korea are limited. This study aimed to address incidence and...
10.
Sung S, Lee S, Hong J, Kang H, Lee S, Kim M, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927993
In the original publication [...].